🎁 Black Friday: up to 50% off of annual plans
Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.640
-0.051 (-3.02%)
Nov 20, 2026, 5:29 PM CET

Oncopeptides AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
103.571.1231.6535.228.36118.3
Revenue Growth
65.69%124.72%-10.14%321.54%-92.94%-
Cost of Revenue
3.62.452.66-1.080.0153.12
Gross Profit
99.968.6728.9936.38.3565.17
Selling, General & Admin
193.26194.62197.28188.48142.2873.81
Research & Development
98.85102.97121.19106.95217.66679.93
Other Operating Expenses
-7.03-3.29-6.9-6.34-4.573.9
Operating Expenses
285.08294.31311.57289.09355.291,558
Operating Income
-185.19-225.64-282.59-252.79-346.94-1,492
Interest Expense
-0.93-14.45-12.66-5.79-0.88-0.95
Interest & Investment Income
1.951.958.28.592.620.49
Currency Exchange Gain (Loss)
3.013.01-1.821.548.9671.54
Other Non Operating Income (Expenses)
-12.33-12.334.66--0
EBT Excluding Unusual Items
-193.49-247.46-284.21-248.45-336.24-1,421
Gain (Loss) on Sale of Investments
-0.71-0.71----
Gain (Loss) on Sale of Assets
-----1.44-
Pretax Income
-194.2-248.17-284.21-248.45-337.68-1,421
Income Tax Expense
1.851.420.40.660.278.95
Net Income
-196.04-249.59-284.61-249.11-337.95-1,430
Net Income to Common
-196.04-249.59-284.61-249.11-337.95-1,430
Net Income Growth
------
Shares Outstanding (Basic)
323227166908275
Shares Outstanding (Diluted)
323227166908275
Shares Change
49.53%36.37%84.14%9.80%9.33%20.72%
EPS (Basic)
-0.61-1.10-1.71-2.76-4.11-19.00
EPS (Diluted)
-0.61-1.10-1.71-2.76-4.11-19.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-192.57-222.88-260.93-279.61-423.02-1,517
Free Cash Flow Per Share
-0.60-0.98-1.57-3.09-5.14-20.14
Gross Margin
96.52%96.55%91.59%103.06%99.93%55.09%
Operating Margin
-178.92%-317.27%-892.91%-717.74%-4152.44%-1261.64%
Profit Margin
-189.41%-350.94%-899.29%-707.30%-4044.90%-1209.11%
Free Cash Flow Margin
-186.06%-313.40%-824.47%-793.89%-5063.03%-1282.16%
EBITDA
-183.05-223.36-280.12-250.35-344.93-1,491
D&A For EBITDA
2.132.282.472.442.011.72
EBIT
-185.19-225.64-282.59-252.79-346.94-1,492